Novavax Posts Positive Phase 2 Data For RSV-F, Stock Surges
August 11, 2015 at 20:01 PM EDT
Novavax shares rose almost 25% today after the company announced positive phase 2 data for a respiratory disease vaccine candidate.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
